The post-transcriptional regulator, microRNA-21 (miR-21), is upregulated in many forms of cancer, as well as, during cardiac hypertrophic growth. To understand its role, we overexpressed it in cardiocytes where it revealed a unique type of cell-to-cell 'linker' in the form of long slender outgrowths/branches. We subsequently confirmed that miR-21 directly targets and down-regulates the expression of sprouty2 (SPRY2), an inhibitor of branching morphogenesis and neurite outgrowths. We found that β-adrenergic receptor ( 2
Introduction
MiRNA are a newly discovered class of post-transcriptional regulators (Lagos-Quintana et al., 2002) . A miRNA is approximately 22 ribonucleotides-long, genetically encoded, with a potential to recognize multiple mRNA targets guided by sequence complementarity and RNAbinding proteins (Lee et al., 1993) . This class of molecules has the capacity to specifically inhibit translation or induce mRNA degradation, through predominantly targeting the 3'-untranslated regions of mRNA. MiRNA are differentially expressed during development and various diseases, thus, implicating them in normal and pathological cellular mechanisms.
Although mammalian miRNAs are commonly known for inhibiting translation vs.
inducing mRNA degradation, there is now substantial evidence to support the latter as well. Farh et al (Farh et al., 2005) showed that predicted mRNA targets of tissue-specific miRNA were lower in the corresponding tissue versus others. In support, Lim et (Lim et al., 2005) showed that by expressing the muscle-specific miR-1 or the brain-specific miR-124 in HeLa cells its mRNA expression pattern shifted accordingly. The mechanism of mRNA degradation is similar to that employed by siRNA, where the endonuclease 'Dicer' mediates mRNA cleavage. Alternatively, miRNA may induce deadenylation, which induces mRNA degradation (Wu et al., 2006) . On the other hand, it is well established that in metazoans miRNA inhibits mRNA translation, for which the Cap and poly(A) tail structures are required for inhibition of translation initiation, but the mechanism remains unknown (Humphreys et al., 2005) . It is plausible that transient exposure of an mRNA to a targeting miRNA will inhibit its translation while chronic exposure will result in its degradation.
MiR-21 is one of the most commonly and highly upregulated miRNA in many forms of cancer (Volinia et al., 2006; Meng et al., 2007) . Its knockdown activates caspases and induces apoptosis in glioblastoma cells (Chan et al., 2005) and sensitizes cholangiocytes to chemotherapeutic agents (Meng et al., 2007) , while its over-expression inhibits apoptosis in myeloma cells (Loffler et al., 2007) . MiR-21 is shown to target and down-regulate the expression of the tumor suppressors tropomyosin 1 , phosphatase and tensin homolog (PTEN) (Meng et al., 2007) , and programmed cell death 4 (Pdcd4) and promote cell invasion and metastasis (Asangani et al., 2007) . Moreover, anti-miR-21 inhibits tumor growth in vivo and in vitro . In human colorectal cancer the levels of miR-21 positively correlated with the development of metastasis but not tumor size (Slaby et al., 2008) . Most interestingly, out of 37 differentially expressed miRNA (26 upregulated and 11 down-regulated) in colon adenocarcinoma, upregulation of miR-21 singularly correlated with lower survival rates and poor response of patients to therapy (Schetter et al., 2008) . Thus, miR-21 is poised to be a major therapeutic target in colon carcinoma.
Cardiac hypertrophy is characterized by a change in the gene expression pattern that recapitulates the neonatal profile (Johnatty et al., 2000) . This switch is triggered by transcriptional and post-transcriptional regulators. Several labs have recently reported an array of post-transcriptional miRNA regulators that are differentially expressed and play a role in the development of cardiac hypertrophy (van Rooij et al., 2006; Callis et al., 2007; Care et al., 2007; Cheng et al., 2007; Sayed et al., 2007; Tatsuguchi et al., 2007) . MiR-21 is one of the most highly and consistently upregulated miRNA, but its role is still controversial Tatsuguchi et al., 2007) . The underlying mechanisms involved in cardiac hypertrophy are reminiscent of those employed in cancer, overlapping in many growth promoting molecules and pathways, wherein miR-21 proves to be no exception (van Rooij et al., 2006; Cheng et al., 2007; Sayed et al., 2007; Tatsuguchi et al., 2007) .
In this study we describe a role for miR-21 in inducing unique connections between cardiocytes, a morphological aspect of the cell that has not been previously described. We also 4 identify an upstream regulatory pathway and a downstream target of miR-21. Their implications in cardiac hypertrophy and cancer are discussed.
Material and Methods
Transverse Aortic Constriction -C57Bl/6 were subjected to transverse aortic constriction as previously described (Sayed et al., 2007) .
Cell cultures and adenovirus Infection-Neonatal cardiocytes were prepared as previously described, using both pre-plating and percoll gradients for enriching for cardiocytes (Abdellatif et al., 1994) . Twenty-four h later medium was replaced without fetal bovine serum (FBS) and cells were infected with recombinant adenoviruses at a multiplicity of infection (moi) of 10-20.
Adult cardiocytes were prepared as previously described (Malhotra et al., 1997) . Briefly, beating hearts were perfused in a Langendorf apparatus with collagenase type II (Worthington Biochemicals) till cardiocytes were dissociated and were then cultured in minimal essential medium with 1.2 mM CaCl 2 on laminin-coated chamber slides.
Colon cancer SW480 and SW620 cell lines (American Tissue Culture Collection) were cultured in Leibovitz's medium (GIBCO) with 10% FBS, at 37 o C in a CO 2 -free incubator. Cells were infected with the various viruses in FBS-free medium.
Northern Blot -Total RNA extracted from whole hearts or cultured cardiocytes were analyzed by Northern blots as previously described (Sayed et al., 2007) .
Construction of Adenoviruses -Recombinant adenoviruses were constructed, propagated and titered as previously described by Dr. Frank Graham (Graham and Prevec, 1991) . The viruses were purified on a cesium chloride gradient followed by dialysis against 20 mM Tris buffered saline with 2% glycerol. (shRNA) SPRY2: a hairpin-forming oligo corresponding to bases 668-688 of ORF of mus musculus SPRY2, GenBankTM accession number NM_011897, was cloned into adenovirus as previously described (Yue et al., 2004) .
Immunocyochemistry -As previously described (Sayed et al., 2007) . Cells were immunolabeled with: anti-titin (Developmental Studies Hybridoma Bank, University of Iowa), anti SPRY2 (Upstate Biotechnologies), anti-connexin43 (BD Biosciences), or anti-βcatenin (Santa Curz), in Tris-buffered saline with 1% bovine serum albumin. Slides were mounted using Prolong Gold anti-fade plus DAPI (Molecular Probes).
Immunohistochemistry -Slides were immunostained with 1:100 anti-connexin43 (BD Biosciences) using BCIP/NBT chromagen from (Zymed), according to the manufacturer's protocol.
Cell fractionation and Western blotting -as previously described (Sayed et al., 2007) were incubated for 5hrs at 37°C. The cells were then fixed with 10% buffered formaline and kept at 4°C overnight, before they were stained with hematoxylin (Zymed). The upper side of the membrane was gently wiped using a wet cotton swab to remove excess stain before the lower side was imaged with an 20 x objective. The number of cells migrated were counted using the free Image J, cell counter software (National Institute of Health).
Statistical Analysis -Calculation of significance between 2 groups was performed using an unpaired, two-tailed, t-test. Experiment in figure 1e was performed twice, while all others were done at least 3 times, as indicated in the figure legends. The relative intensities of the bands seen on Western blot or Northern blot radiographs were quantified using Un-scan-it software and normalized to an internal control such as glyceraldehyde phosphate dehydrogenase (GAPDH), 
Results

MiR-21 is upregulated during cardiac hypertrophy and through stimulation of the β-adrenergic receptor
We have previously reported an array of microRNAs including miR-21 that was upregulated during cardiac hypertrophy (Sayed et al., 2007) . MiR-21 increases by 4 ± 1.5 and 8.3 ± 0.6 fold (n=3 averaged ± SD), at 7 and 14 day, respectively, post-induction of hypertrophy using transverse aortic constriction (TAC) versus a sham operation in a mouse model (Fig. 1a) .
This was associated with 27 ± 6 % and 35 ± 5 %, (n=4 averaged ± SD) increase in heart / body weight, respectively, and an increase in skeletal actin, which is a marker of hypertrophy (Fig. 1a) .
The increase in miR-21 was sustained through 18 days post-TAC but started declining thereafter, concurrent with the onset of cardiac dysfunction (decompensation). We also assessed the levels 8 of miR-21 in other genetic mouse models of cardiomyopathies, the results of which revealed its upregulation in a transgenic mouse over-expressing β2-adrenergic receptor (β2AR) in the heart prior to development of any phenotype (Fig. 1b) . βAR stimulation plays a role in the development of cardiac hypertrophy, where studies have shown that infusion of its agonist, isoproterenol, increases cardiac contractility and hypertrophy in rodent models. We further confirmed that isoproterenol induces upregulation of miR-21 in isolated rat cardiocytes to almost the same extent as seen in the transgenic hearts ( Fig. 1c-d ). This suggests that the βAR receptors are upstream regulators of miR-21. Mir-21, which is ubiquitously expressed in adult human and mouse tissue, is relatively low in the normal adult heart (Supplementary Fig. 1s ). It is developmentally regulated, which in contrast to the muscle specific miR-1 is higher in the neonatal heart that is known to grow though a process of cardiocyte hypertrophy (Fig. 1e) . Thus, an increase in miR-21 accompanies hypertrophic growth, with the βAR receptor being one of its upstream regulators.
Mir-21 targets sprouty2 and induces cellular outgrowths
In order to address the role of miR-21 in cardiocytes we cloned a 320 nt sequence that encompasses the miR-21 stem-loop into a recombinant adenovirus (Fig. 2a) . We similarly cloned a tandem repeat of the anti-sense sequence of mature miR-21 under the control of the U6 promoter ( Fig. 2b) . Northern blots analysis of cardiocytes treated with the former vector exhibit ~3 fold higher mature miR-21 versus control, although the premature construct accumulated at much higher levels, reflecting a rate limiting step in the processing of miR-21 (Fig. 2a) . On the other hand, the anti-sense miR-21 was highly expressed and resulted in knockdown of endogenous miR-21, but not miR-1, where it was undetectable by Northern blotting (Fig. 2b ).
For that reason we dubbed this construct 'miR-21 eraser'. The function of this eraser was further validated in SW480 and SW620 cancer cells with regards to the established miR-21 targets, programmed cell death 4 and phosphatase and tensin homolog deleted on chromosome 10 9 (PTEN, supplementary Fig. 2s-a-d) . We also established the specificity and versatility of these erasers by showing that a 'miR-199a eraser' specifically eliminated the corresponding miRNA but not miR-21 or miR-1 (supplementary Fig. 2s -e).
Over-expressing miR-21 in cardiocytes did not influence hypertrophic growth in the absence or presence of growth factors as monitored by [3H]leucine incorporation (data not shown). But after 48-72 h in culture we noticed all the cells exhibited extensive cellular outgrowths (4 ± 3 branches / cell, n=25 averaged ± SD) that varied in length (44 ± 28 µm, n=25
averaged ± SD) depending on the distance between neighboring cells (Fig. 2c) . Sprouty, a known inhibitor of branching morphogenesis and neurite outgrowth, is predicted to be a miR-21 target by TargetScanS and PicTar miRNA target prediction software, each using a unique set of algorithms. To confirm its potential in mediating miR-21's branching effects, we independently knocked it down using adenoviral delivered short-hairpin RNA (see Fig. 2f ). This elicited even more impressive cardiocyte outgrowths (Fig. 2c) . Neither miR-21 nor the shRNA against SPRY2
had any effect on SPRY1, 3, or 4 (supplementary Fig. 3s) . Furthermore, over-expression of SPRY2 inhibited miR-21-induced outgrowths (Fig. 2d) , which suggested that miR-21's effect is mediated through this putative target.
Using Western blot analysis we confirmed down-regulation of endogenous SPRY2 (52 ± 4 %, n=4 averaged ± SD) upon over-expression of miR-21 for 48 hr (Fig. 2e) . The blots also revealed that the SPRY2 protein is present in the cytosol, membrane, nuclear, and cytoskeletal fractions of cardiocytes (supplementary Fig. 4s ). It should be noted that SPRY2 is detected as 2-3 bands on an SDS-PAGE, which is thought to be due to its phosphorylation and palmitoylation (Impagnatiello et al., 2001) . The quantification takes into account all 3 forms. On the other hand, over-expression of SPRY2 had no effect on endogenous miR-21 (supplementary Fig. 5s ). Since sprouty negatively regulates erk1/2, we used phospho-erk1/2 as a marker for monitoring changes in Spry2 function that would be regulated by changes in its levels. The results of this show that downregulation of SPRY2 by miR-21 or shRNA (67 ± 9%, n=4 averaged ± SD) is accompanied by an increase in basal phosph-erk1/2 normalized to the total erk by 5 ± 0.4 (n=4 averaged ± SD) and 2.2 ± 0.15 fold (n=4 averaged ± SD), respectively ( Fig. 2e-f ). But excess (over-expressed) miR-21 did not augment FBS-induced phospho-erk1/2 levels, plausibly FBS has already induced maximal stimulation (supplementary Fig. 4s-b) . The increase of phospho-erk1/2 by these treatments may reflect the inhibitory effect of SPRY2 on basal activation of surface receptors through autocrine effects. In contrast, knockdown of miR-21 using the miR-21 eraser, or overexpression of SPRY2, result in > 80% inhibition of fetal bovine serum-induced phospho-erk1/2
( Fig. 2g-h ). Thus, SPRY2 is a downstream target of miR-21 (could be a direct or indirect target at this juncture) and has limiting cellular concentrations.
To determine if SPRY2 is a direct target of miR-21, we cloned the miR-21 predicted target sequence that is contained within its 3'UTR, downstream of a luciferase gene (Luc.SPRY2, Fig. 2i ). This sequence conferred miR-21-induced inhibition of the luciferase activity by 76 ± 4%
(n=12 averaged ± SEM). To determine specificity, we cloned a mutated miR-21 SPRY2 target sequence, in which the seed-binding sequence was completely altered (Luc.mtSPRY2), downstream of the luciferase gene. As seen in figure 2i , not only did this mutant abolish the effect of exogenous miR-21 on the reporter, but it also relieved it from inhibition by the endogenous miR-21. Thus, we conclude that SPRY2 is a direct target of miR-21.
β-adrenergic receptor stimulation induces down-regulation of SPRY2, which is accompanied by cell-to-cell connecting cellular outgrowths
To address physiological relevance of these miR-21-induced outgrowths we asked whether these structures accompany βAR-induction of miR-21 in isolated cardiocytes. After treatment of the cells with isoproterenol and staining them with an antibody against the sarcomeric protein titin, we were able to observe cellular outgrowth that were connecting or reaching out to adjacent cells (Fig. 3a, upper panels) . The striated pattern of titin staining reflects the presence of sarcomeres even within these branches. This effect was wide spread in all observed cells (4 ± 3 branches / cell, n=20 averaged ± SD). Impressively, these outgrowths were abrogated by the miR-21 eraser or over-expression of SPRY2 (Fig. 3a, lower panel) . Coimmunostaining the cells with anti-SPRY2 reveals that SPRY2 is depressed in the presence of isoproterenol but restored in the presence of the miR-21 eraser or exogenous SPRY2. Similar results were obtained when cells were treated a virus over-expressing β2AR (supplementary Fig.   6s ). While figure 1 confirms that isoproterenol and β2AR induce upregulation of miR-21, figure   3b confirms that they also induce 70 ± 22% and 64 ± 11 (n=3 averaged ± SD) downregulation of SPRY2 protein, respectively (Fig. 3b) . The functional consequence of this effect is reflected in the contractile behavior of the cardiocytes (Fig. 3c) . Normally, isolated cells have variable beating rates. In the presence of isoproterenol the rate of contraction is immediately enhanced 2-5 folds and does not appear to suffer in the absence of miR-21. But after 24 h of stimulation the cardiocytes are hypertrophied and form cell-to-cell connections and begin to beat synchronously.
By disrupting the connecting cellular outgrowth, using miR-21 eraser, this synchronicity of beating is disrupted. Thus, cell-cell connecting cardiocyte outgrowths are a morphological change that accompanies βAR stimulation and hypertrophy, and is mediated by miR-21 through downregulation of SPRY2. From the contractile behavior of the cells we predicted that these outgrowths connect the cardiocytes via functional gap junctions, which we test next.
Cellular outgrowths connect to cardiocytes via gap junctions
To verify the type of cell-cell connections conferred by these outgrowths we immunostained Ad.miR-21-or isoproterenol-treated cardiocytes with anti-connexin43 (Cx43) and anti-βcatenin for detection of gap or adherens/tight junctions, respectively. Our results show that isoproterenol treatment (Fig. 4a, lower panel) , relative to control (Fig. 4a, upper panel) , induced interconnecting branches accompanied by redistribution of Cx43 and βcatenin that became distinctly localized at branch-to-cell contact points. It appears that Cx43 alone is more prevalent at these connections (white arrowheads), where βcatenin was occasionally found to coexist (yellow arrowheads). While miR-21 induced a similar effect, the redistribution of Cx43 and βcatenin at the connection sites was less pronounced (Fig. 4a, calcein-only positive cell (white arrowheads), where the transferring dye could also be seen in the connecting branch (Fig. 4b) . Thus, interconnecting cardiocyte branches serve the purpose of conduction of molecules between cells.
Since the experiments described above were performed in neonatal cultured cardiocytes, which are generally more plastic, we questioned how these outgrowths might develop in the morphologically uniform rod-shaped adult cardiocytes in vivo. For this purpose we sectioned hypertrophied hearts from the TAC mouse model and immunostained them with anti-Cx43.
Compared to normal hearts, these showed connecting, short, lateral outgrowths between adjacent cardiocytes, where Cx43, which is normally strictly localized to the intercalated discs, demarcated the sites of contact (Fig. 5a ). The figure shows three different depictions of these connections. To determine if miR-21 mediates this effect, we isolated normal adult cardiocytes that we treated with the miR-21-expressing adenovirus for 72 h. After immunostaining with antiCx43 we were able to observe Cx43-demarcated lateral protrusions (Fig. 5b, arrowheads) . We also determined the levels of SPRY2 in the hypertrophied heart. The change in SPRY2 protein 13 was only detected in the slower migrating form (~90 %, n=3), both in the membrane and nuclear fractions, but was not associated with an increase in phosph-erk1/2 (Fig. 5c) . Thus, the upregulation of miR-21 in the adult cardiocytes evokes a rudimentary form of the cellular outgrowths observed in the neonatal cardiocytes.
Mir-21 mediates the formation of microvillus-like protrusions in colon cancer cells
MiR-21 is over-expressed in many cancer forms. To determine how the effect of miR-21 seen in cardiocytes translates in cancer cells, we over-expressed miR-21, SPRY2, or miR-21 eraser, in the colon cancer cells SW480. Over-expression of miR-21 results in a minimal increase over the already very high endogenous levels, while miR-21 eraser results in ~70% (n=2) reduction in endogenous miR-21 (Fig. 6a ) accompanied by upregulation of SPRY2 protein (Fig.   6c ). Staining the cells with actin-binding phalloidin reveals microvillus-like protrusions that are enriched throughout the circumference of the control and miR-21 over-expressing cells alike (Fig.   6b ). In contrast, SPRY2 and miR-21 eraser resulted in dramatic reduction of these protrusions.
Immunostaining the cells confirmed an increase in SPRY2 accompanying miR-21 eraser or SPRY2 over-expression. In addition to a reduction of the microvilli-like structures, miR-21 knockdown was associated with a 0.4 ± 0.12 fold lower cell migration relative to control, which was almost completely rescued by shRNA-SPRY2 (Fig. 6c) . Conversely, shRNA-SPRY2 alone increased cell migration 1.47 ± 0.05 fold that was inhibited by miR-21 eraser. Western blot analysis demonstrates the corresponding changes in SPRY2 levels, which reflects its increase with miR-21 eraser, inhibition by shRNA-SPRY2, and its inverse correlation with the extent of migration. Thus, we conclude that miR-21, through inhibition of SPRY2, reduces the formation of microvillus-like protrusions and migration of colon cancer cells.
Discussion
MiR-21, its association with cell growth and its upstream regulators
Mir-21 has attracted more attention than any other miRNA, as it is one of the most highly upregulated in various cancers, cardiac hypertrophy, and neointimal formation, suggesting that it has a fundamental role in cell growth. In agreement, its level is fairly higher in the neonatal vs.
adult heart (Fig. 1e) , where it is upregulated upon induction of hypertrophic growth. On the other hand, its level starts declining with the onset of cardiac failure, ultimately dropping to basal amounts. This also coincides with down-regulation and desensitization of the βARs (Bristow et al., 1982) . Moreover, β2AR-over-expressing mice exhibit upregulation of miR-21 in the heart, while isoproterenol stimulation of cultured cardiocytes induces upregulation of miR-21, downregulation of SPRY2 and enhanced myocyte branching. Collectively, these data suggest that βARs are upstream regulators of miR-21 in the heart. Interestingly, it was recently reported that stress mediated through βAR stimulation enhances ovarian cancer cell invasiveness (Sood et al., 2006) . Thus, it is also plausible that βAR also plays a role in enhancing miR-21 in cancer cells, where it may induce upregulation of miR-21, down-regulation of SPRY2, and increased microvillus-like protrusions and, thereby, cell migration.
Evidence supporting a role for βAR in inducing cardiocyte connectivity and its association with cardiac hypertrophy
In support of a role for βAR stimulation in cell-cell connections and conduction, it was recently reported to increase the expression of connexin43 (Salameh et al., 2006) and conduction velocity in cultured neonatal cardiocytes (de Boer et al., 2007) . Conduction velocity, which is partly regulated by the abundance of gap junctions, is increased during early hypertrophy but decreased during later decompensation stages (Cooklin et al., 1998) , which coincides with the decline in βARs and connexin43. Similarly, stretch (Zhuang et al., 2000) and cAMP (Darrow et al., 1996) , induce upregulation of connexin43 and gap junction density in parallel with an increase in conduction velocity in cultured cardiocytes. These data reconcile well with our results in figure 3a showing extensive interconnecting cellular branches induced by isoproterenol treatment of isolated cardiocytes.
Cardiocytes adjacent to infarct zones (Smith et al., 1991) or those subjected to aortic banding-induced hypertrophy (Emdad et al., 2001) or pulmonary hypertension-induced hypertrophy (Uzzaman et al., 2000) , exhibit extensive remodeling of gap junctions. This remodeling is in the form of punctate distribution of connexin43 throughout the perimeter of the cell, which is normally confined to its end intercalate discs. This is similar to its diffuse distribution in neonatal heart cardiocytes (Spach et al., 2000) . Interestingly, we observe a similar pattern of connexin43 labeling after TAC and in isolated adult cardiocytes over-expressing miR-21 (Fig. 5b) . We propose that the lateralization of connexin43 demarcate sites of cell-to-cell connecting branches, which are induced by upregulation of miR-21 and down-regulation of its target SPRY2. Similarly, in normal human hearts connexin43 is predominantly (91.7%) restricted to the intercalated discs (Kostin et al., 2004) . During early stages of cardiac hypertrophy connexin43 is increased by 44.3%, but only 60.3% is localized to intercalated discs while more of the protein appears on the lateral sarcolemma (Kostin et al., 2004) . But during later stages of hypertrophy and decompensation, connexin43 levels are reduced and the lateral distribution disappears. This distribution and expression profile of connexin43 agrees with a scenario in which increased miR-21 during compensatory hypertrophy is associated with increased Cx43-positive, cell-cell connecting side branches, which is reversed during failure commensurate with the decline of miR-21.
The role of SPRY in branching and cancer
Sprouty was first discovered as an inhibitor of FGF signaling and branching of Drosophila airways (Hacohen et al., 1998) . This effect is conserved as shown by knockdown of SPRY2 in mouse lungs (Tefft et al., 1999) . Sprouty inhibits MAPK activation by fibroblast growth factor (FGF) and epidermal growth factor (EGF) (Reich et al., 1999) . Inhibition of branching is not restricted to the lungs, but SPRY2 also inhibits ureteric (Chi et al., 2004) , as well as, chorionic vellous branching and reduces trophoblast cell migration (Chi et al., 2004) .
Although the branches referred to here are tubular multicellular structures that underlie organogenesis, they are initiated by single cell sprouting. But most relevant to our study, is inhibition of neurite outgrowths by SPRY2 (Lao et al., 2006; Gross et al., 2007) .
A related isoform, SPRY1, was reported to be upregulated after relieving a human heart from its workload, which is consistent with our finding in which SPRY2 is down-regulated during pressure overload (Huebert et al., 2004) . SPRY was also found in vascular endothelial cells and has been shown to inhibit vasculargenesis (Huebert et al., 2004) . Likewise, sprouty4
inhibits FGF and vascular endothelial growth factor (VEGF)-induced endothelial cell migration and proliferation (Lee et al., 2001) , while SPRY2 inhibits migration and proliferation of smooth muscle cells (Zhang et al., 2005) . This reconciles well with the observed upregulation of miR-21 during neointimal formation, which has been shown to enhance smooth muscle proliferation , and our discovery of SPRY2 being one of its targets.
Sprouty is down-regulated in prostrate cancer (Kwabi-Addo et al., 2004) , breast cancer (Lo et al., 2004) , hepatocellular carcinoma (Fong et al., 2006) , and non-small cell lung cancer (Sutterluty et al., 2007) . While independently, it was shown that these forms of cancer are also associated with upregulation of miR-21 (Volinia et al., 2006; Meng et al., 2007) . Whereas overexpression of SPRY2 inhibits cell migration (Yigzaw et al., 2001; Lee et al., 2004) , an increase in miR-21 enhances cell proliferation and migration (Meng et al., 2007) . This is consistent with a pathway in which upregulated miR-21 targets and down-regulates SPRY2, thereby, enhancing proliferation and migration. But in addition, it has been shown that miR-21 can contribute to carcinogenesis through inhibition of apoptosis, or downregulation of other tumor suppressors, such as phosphatase and tensin homolog deleted on chromosome 10 (PTEN) (Meng et al., 2007) and tropomyosin 1 (TPM1) . This further establishes a link between miR-21 and SPRY2, which is known to induce upregulation of PTEN and inhibit cell proliferation (Edwin et al., 2006) . Using the miR-21 eraser in cancer cells, we show that knockdown of miR-21 is associated with upregulation of both SPRY2 and PTEN. Thus, it appears that miR-21 negatively regulates PTEN both, directly, and indirectly through inhibition of SPRY2. Moreover, SPRY2 differentially regulates apoptosis, where in differentiated neuronal cells it is apoptotic (Gross et al., 2007) , but is anti-apoptotic in adenocarcinoma cells (Edwin and Patel, 2008) . Our results suggest that miR-21 through down-regulating SPRY2 enhances migration through promoting formation of microvillus-like protrusions. But the possibility remains that miR-21 through inhibition of SPRY2 and PTEN enhances cancer cell proliferation as well. Also, while validating the function of our miR-21 eraser we found that it upregulates PDCD4 in SW480 but not in myocytes, corroborating an anti-apoptotic effect of miR-21 in cancer cells.
The 'eraser' is a powerful tool for specific knockdown of endogenous miRNA
Inhibition or knockdown of a specific miRNA is key in understanding its function. For that purpose several approaches have been devised. Those include the 2'-O-methyl (Hutvagner et al., 2004; Meister et al., 2004) or LNA-modified oligoribonuleotides (Orom et al., 2006) , and 'antagomirs', which have a phosphorothioate backbone, a cholesterol-moiety at 3'-end, and 2'-Omethyl modifications (Krutzfeldt et al., 2005) . In contrast to these transiently delivered oligonucleotides, Ebert et al have recently reported the delivery of anti-sense miRNA sequence using expression vectors termed 'sponges' (Ebert et al., 2007) . Our 'miRNA eraser' is similar in concept to the latter, but differs in the mechanism of inhibition of the miRNA. While the sponges induce a modest variable decrease of the endogenous miRNA our 'eraser' wipes it out. The apparent loss of the miRNA signal on the Northern blots cannot be explained by competition of the complementary eraser RNA with the labeled miRNA probe used for the detection, as
proposed by Ebert et al, since Northern blots are normally run under extreme denaturing conditions. In cardiocytes, it miR-specific erasers rendered endogenous miR-21 and miR-199a undetectable on Northern blots. In colon cancer cells, though, the effect was less complete only because it was diluted out by the rapidly proliferating cultures. The eraser differs from the sponge in 2 physical aspects; one, the lack of stem-loop sequences at the 5' and 3' ends of tandem repeat sequence and, two, its delivery via a viral vector. Other plausible reasons for the difference in the outcome are the nature of the cell types or the targeted microRNA tested in both studies.
Conclusion
In conclusion, miR-21 plays a role in inducing the formation of cellular outgrowths that connect cardiocytes through gap junctions, which are usually confined to the intercalated discs in the normal adult heart. This change is provoked by βAR stimulation and mediated through down-regulation of SPRY2, an established negative regulator branching morphogenesis. We propose that this is an adaptive effect seen during cardiac hypertrophic growth and is associated with gap junction remodeling and enhanced conduction velocity but is reversed during cardiac connections and down-regulation of SPRY2. a. Twelve weeks old male C57Bl/6 mice were subjected to TAC. Two weeks later the hearts were isolated fixed, sectioned, and immunostained with anti-Cx43 (dark purple) and counterstained with haematoxylin (blue nuclei, n=3).
Arrowheads point to connecting side branches. b. Adult rat cardiocytes were cultured on laminin-coated chamber slides. The cells were then infected with 20-40 moi of Ad expressing miR-21 or a control scrambled sequence (n=3). After 48 hr they were fixed and immunolabeled with anti-Cx43 (red). Cells were imaged with an epifluorescence microscope at 60x magnification. c. From hearts similar to those described in (a.) cellular protein was extracted, fractionated into cytoplasm (Cyto), membrane (Mem), nuclei (Nuc), and cytoskeleton (CytoSk), and analyzed by Western blotting using anti-SPRY2, anti-Ras GTPase-activating protein (RasGAP), anti-p-p42/p44, and anti-p42/p44 (n=3). Anti-Ras, anti-histone H2B, and anti-skeletal actin (SkAc) are used to validate the membrane, nuclear, and sarcomeric fractions, respectively, while anti-RasGAP validates the cytosolic fraction objective, and counted on the bottom side of the filter from 3 fields / well using the Image J, cell counter software (NIH). The difference in cell migration seen with the various treatments was calculated as fold change relative to the control treatment after adjusting it to 1, and is plotted as a bar graph with error bars representing standard error of the mean and *'s representing p < 0.001 31 calculated for miR-21eraser-or shRNA-SPRY2-vs. control-treated cells. Protein extracts from similarly treated cells were analyzed by a Western blot for SPRY2, which is displayed below the graph (n=2).
